Not for publication, distribution, or release, directly or indirectly, in whole or in part, within or into the
Today is the first day of the subscription period in
Summary of the rights issue
- Each shareholder who on the record date,
8 September 2022 , was registered in the Company’s share register will, in the Rights Issue, be entitled to one (1) subscription right for each share owned in the Company. The subscription right entitles the holder the right to subscribe for ordinary shares, whereby six (6) subscription rights entitle the holder to subscribe for one (1) new ordinary share. - The Rights Issue comprises up to 6,599,399 ordinary shares.
- The subscription price in the Rights Issue is
SEK 6.44 . Egis Technology has undertaken to guarantee approximately a fourth of the Rights Issue free of charge. In addition, the Company has received subscription undertakings from all shareholding members of the Board of Directors and Management in Precise regarding their pro rata share of the Rights Issue as well as from the board directorPeter Gullander , amounting to approximately 2.7 percent of the Rights Issue in total. The Rights Issue is thus guaranteed to approximately 27.7 percent.- In connection with the Rights Issue, all shareholding members of the Board of Directors and Management in Precise have contractually committed to
Vator Securities AB not to, with customary exceptions, sell shares or carry out other transactions with the equivalent effect of a sale without, in each individual case, first have obtained a written approval fromVator Securities AB . The lock-up period lasts from the day of the agreement until the day that falls 90 days after the end of the subscription period in the Rights Issue. Furthermore,Egis Technology has, through an investment agreement and with customary exceptions, committed to the Company not to, for a period of 24 months after the decision on the directed issue and the Rights Issue, sell the shares in the Company thatEgis Technology receives through the directed issue, the Rights Issue and, where applicable, the over-allotment option without, in each individual case, having first obtained written approval from the Company
For full terms and conditions of the Rights Issue, please refer to the prospectus published by the Company on
Preliminary time plan for the Rights Issue
Trading in subscription rights | |
Subscription period | |
Trading in BTA ("Paid Subscribed Share") on Nasdaq Stockholm | |
Publication of the outcome of the Rights Issue |
Prospectus and application forms
The prospectus, which includes the full terms and conditions of the Rights Issue, is available on the Company website, www.precisebiometrics.com, Vator Securities’ website, www.vatorsecurities.se, and the Financial Supervisory Authority’s prospectus register, https://fi.se/sv/vara-register/prospektregistret/.
Application forms are available on Precise’s and Vator Securities’ website.
Advisors
For more information, please contact:
E-mail: patrik.hoijer@precisebiometrics.com
This information was submitted for publication at
Important information
The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such restrictions. This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction.
Any offer of securities in the Company mentioned in this press release will be made through a prospectus or with an applicable exemption in accordance with the Prospectus Regulation. This press release is not a prospectus according to Regulation (EU) 2017/1129 and Directive 2003/71 / EC (together with relevant implementations and delegated regulations "Prospectus Regulation").
No securities described herein have been, nor will they be, registered under the
In the
Within the European Economic Area (“EEA”), no public offering of securities is made in other countries than
© Modular Finance, source